Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

As the Government promises GP practices open seven days a week, 12 hours a day, by 2020, RealityBites discusses…

Open data policies need to become as commonplace as health and safety policies. Opening up needs champions in…

As the recession took hold the public sector was quick to embrace online travel booking. The private sector is…

With optimism slowly but surely returning to the UK economy, many of those organisations that made significant…

English City regions want some of what Scotland's having. Devo Manchester is pushing to the head of the queue.…

The funding crisis in the NHS means we must start a debate on how we can link choices we make to look after our…

Last week’s Scottish independence NO vote brought wider English regional devolution two steps closer. Suppliers…

Every weekday Public Service Intelligence publishes a subscription service focussing on local council news and…

Do you do digital? Take the test

The Information Daily is collaborating with Socitm to research organisations' commitment to and capability for a digital future.

Take the test

View Results

If you have already taken the test, you may view the latest detailed results by entering your email address below


Headline results so far: Results from 108 users

Corporate commitment: 46%
0%
100%
50%
Digital capability: 53%
0%
100%
50%

In January this year, Coverity submitted a series of freedom of information (FOI) requests to all the UK’s…

Margaret Thatcher and Che Guevara would have made an unlikely alliance. But that’s what happened earlier…

Every weekday Public Service Intelligence publishes a subscription service focussing on local council news and…

Every medical professional in the UK, to one degree or another, today faces the challenge of managing a growing…